View in EDS HTML Full Text PDF Full Text

Cannabidiol and Terpene Formulation Reducing SARS-CoV-2 Infectivity Tackling a Therapeutic Strategy.

Saved in:
Bibliographic Details
Title: Cannabidiol and Terpene Formulation Reducing SARS-CoV-2 Infectivity Tackling a Therapeutic Strategy.
Authors: Santos S; R&D&Innovation Department, EXMceuticals Portugal Lda, Lisboa, Portugal.; Cooperativa de Formação e Animação Cultural - Centre for Interdisciplinary Development and Research on Environment, Applied Management and Space (COFAC-DREAMS)-Universidade Lusófona, Lisboa, Portugal., Barata P; LABMI - Laboratório de Biotecnologia Médica e Industrial, PORTIC - Porto Research, Technology and Innovation Center, Porto, Portugal.; Metabesity Deopartment, i3S - Instituto de Investigação e Inovação em Saúde, Porto, Portugal., Charmier A; R&D&Innovation Department, EXMceuticals Portugal Lda, Lisboa, Portugal.; Cooperativa de Formação e Animação Cultural - Centre for Interdisciplinary Development and Research on Environment, Applied Management and Space (COFAC-DREAMS)-Universidade Lusófona, Lisboa, Portugal., Lehmann I; R&D&Innovation Department, EXMceuticals Portugal Lda, Lisboa, Portugal., Rodrigues S; R&D&Innovation Department, EXMceuticals Portugal Lda, Lisboa, Portugal., Melosini MM; R&D&Innovation Department, EXMceuticals Portugal Lda, Lisboa, Portugal., Pais PJ; LABMI - Laboratório de Biotecnologia Médica e Industrial, PORTIC - Porto Research, Technology and Innovation Center, Porto, Portugal.; Metabesity Deopartment, i3S - Instituto de Investigação e Inovação em Saúde, Porto, Portugal., Sousa AP; LABMI - Laboratório de Biotecnologia Médica e Industrial, PORTIC - Porto Research, Technology and Innovation Center, Porto, Portugal.; Metabesity Deopartment, i3S - Instituto de Investigação e Inovação em Saúde, Porto, Portugal.; Escola Superior de Saúde, Instituto Politécnico do Porto, Porto, Portugal., Teixeira C; LABMI - Laboratório de Biotecnologia Médica e Industrial, PORTIC - Porto Research, Technology and Innovation Center, Porto, Portugal.; Metabesity Deopartment, i3S - Instituto de Investigação e Inovação em Saúde, Porto, Portugal.; Escola Superior de Saúde, Instituto Politécnico do Porto, Porto, Portugal., Santos I; LABMI - Laboratório de Biotecnologia Médica e Industrial, PORTIC - Porto Research, Technology and Innovation Center, Porto, Portugal.; Metabesity Deopartment, i3S - Instituto de Investigação e Inovação em Saúde, Porto, Portugal.; Escola Superior de Saúde, Instituto Politécnico do Porto, Porto, Portugal., Rocha AC; LABMI - Laboratório de Biotecnologia Médica e Industrial, PORTIC - Porto Research, Technology and Innovation Center, Porto, Portugal.; Metabesity Deopartment, i3S - Instituto de Investigação e Inovação em Saúde, Porto, Portugal., Baylina P; LABMI - Laboratório de Biotecnologia Médica e Industrial, PORTIC - Porto Research, Technology and Innovation Center, Porto, Portugal.; Metabesity Deopartment, i3S - Instituto de Investigação e Inovação em Saúde, Porto, Portugal.; Escola Superior de Saúde, Instituto Politécnico do Porto, Porto, Portugal., Fernandes R; LABMI - Laboratório de Biotecnologia Médica e Industrial, PORTIC - Porto Research, Technology and Innovation Center, Porto, Portugal.; Metabesity Deopartment, i3S - Instituto de Investigação e Inovação em Saúde, Porto, Portugal.; Escola Superior de Saúde, Instituto Politécnico do Porto, Porto, Portugal.
Source: Frontiers in immunology [Front Immunol] 2022 Feb 15; Vol. 13, pp. 841459. Date of Electronic Publication: 2022 Feb 15 (Print Publication: 2022).
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35242142
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Cannabidiol and Terpene Formulation Reducing SARS-CoV-2 Infectivity Tackling a Therapeutic Strategy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Santos+S%22">Santos S</searchLink>; R&D&Innovation Department, EXMceuticals Portugal Lda, Lisboa, Portugal.; Cooperativa de Formação e Animação Cultural - Centre for Interdisciplinary Development and Research on Environment, Applied Management and Space (COFAC-DREAMS)-Universidade Lusófona, Lisboa, Portugal.<br /><searchLink fieldCode="AU" term="%22Barata+P%22">Barata P</searchLink>; LABMI - Laboratório de Biotecnologia Médica e Industrial, PORTIC - Porto Research, Technology and Innovation Center, Porto, Portugal.; Metabesity Deopartment, i3S - Instituto de Investigação e Inovação em Saúde, Porto, Portugal.<br /><searchLink fieldCode="AU" term="%22Charmier+A%22">Charmier A</searchLink>; R&D&Innovation Department, EXMceuticals Portugal Lda, Lisboa, Portugal.; Cooperativa de Formação e Animação Cultural - Centre for Interdisciplinary Development and Research on Environment, Applied Management and Space (COFAC-DREAMS)-Universidade Lusófona, Lisboa, Portugal.<br /><searchLink fieldCode="AU" term="%22Lehmann+I%22">Lehmann I</searchLink>; R&D&Innovation Department, EXMceuticals Portugal Lda, Lisboa, Portugal.<br /><searchLink fieldCode="AU" term="%22Rodrigues+S%22">Rodrigues S</searchLink>; R&D&Innovation Department, EXMceuticals Portugal Lda, Lisboa, Portugal.<br /><searchLink fieldCode="AU" term="%22Melosini+MM%22">Melosini MM</searchLink>; R&D&Innovation Department, EXMceuticals Portugal Lda, Lisboa, Portugal.<br /><searchLink fieldCode="AU" term="%22Pais+PJ%22">Pais PJ</searchLink>; LABMI - Laboratório de Biotecnologia Médica e Industrial, PORTIC - Porto Research, Technology and Innovation Center, Porto, Portugal.; Metabesity Deopartment, i3S - Instituto de Investigação e Inovação em Saúde, Porto, Portugal.<br /><searchLink fieldCode="AU" term="%22Sousa+AP%22">Sousa AP</searchLink>; LABMI - Laboratório de Biotecnologia Médica e Industrial, PORTIC - Porto Research, Technology and Innovation Center, Porto, Portugal.; Metabesity Deopartment, i3S - Instituto de Investigação e Inovação em Saúde, Porto, Portugal.; Escola Superior de Saúde, Instituto Politécnico do Porto, Porto, Portugal.<br /><searchLink fieldCode="AU" term="%22Teixeira+C%22">Teixeira C</searchLink>; LABMI - Laboratório de Biotecnologia Médica e Industrial, PORTIC - Porto Research, Technology and Innovation Center, Porto, Portugal.; Metabesity Deopartment, i3S - Instituto de Investigação e Inovação em Saúde, Porto, Portugal.; Escola Superior de Saúde, Instituto Politécnico do Porto, Porto, Portugal.<br /><searchLink fieldCode="AU" term="%22Santos+I%22">Santos I</searchLink>; LABMI - Laboratório de Biotecnologia Médica e Industrial, PORTIC - Porto Research, Technology and Innovation Center, Porto, Portugal.; Metabesity Deopartment, i3S - Instituto de Investigação e Inovação em Saúde, Porto, Portugal.; Escola Superior de Saúde, Instituto Politécnico do Porto, Porto, Portugal.<br /><searchLink fieldCode="AU" term="%22Rocha+AC%22">Rocha AC</searchLink>; LABMI - Laboratório de Biotecnologia Médica e Industrial, PORTIC - Porto Research, Technology and Innovation Center, Porto, Portugal.; Metabesity Deopartment, i3S - Instituto de Investigação e Inovação em Saúde, Porto, Portugal.<br /><searchLink fieldCode="AU" term="%22Baylina+P%22">Baylina P</searchLink>; LABMI - Laboratório de Biotecnologia Médica e Industrial, PORTIC - Porto Research, Technology and Innovation Center, Porto, Portugal.; Metabesity Deopartment, i3S - Instituto de Investigação e Inovação em Saúde, Porto, Portugal.; Escola Superior de Saúde, Instituto Politécnico do Porto, Porto, Portugal.<br /><searchLink fieldCode="AU" term="%22Fernandes+R%22">Fernandes R</searchLink>; LABMI - Laboratório de Biotecnologia Médica e Industrial, PORTIC - Porto Research, Technology and Innovation Center, Porto, Portugal.; Metabesity Deopartment, i3S - Instituto de Investigação e Inovação em Saúde, Porto, Portugal.; Escola Superior de Saúde, Instituto Politécnico do Porto, Porto, Portugal.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2022 Feb 15; Vol. 13, pp. 841459. <i>Date of Electronic Publication: </i>2022 Feb 15 (<i>Print Publication: </i>2022).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35242142
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fimmu.2022.841459
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 841459
    Titles:
      – TitleFull: Cannabidiol and Terpene Formulation Reducing SARS-CoV-2 Infectivity Tackling a Therapeutic Strategy.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Santos S
      – PersonEntity:
          Name:
            NameFull: Barata P
      – PersonEntity:
          Name:
            NameFull: Charmier A
      – PersonEntity:
          Name:
            NameFull: Lehmann I
      – PersonEntity:
          Name:
            NameFull: Rodrigues S
      – PersonEntity:
          Name:
            NameFull: Melosini MM
      – PersonEntity:
          Name:
            NameFull: Pais PJ
      – PersonEntity:
          Name:
            NameFull: Sousa AP
      – PersonEntity:
          Name:
            NameFull: Teixeira C
      – PersonEntity:
          Name:
            NameFull: Santos I
      – PersonEntity:
          Name:
            NameFull: Rocha AC
      – PersonEntity:
          Name:
            NameFull: Baylina P
      – PersonEntity:
          Name:
            NameFull: Fernandes R
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 15
              M: 02
              Text: 2022 Feb 15
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1664-3224
          Numbering:
            – Type: volume
              Value: 13
          Titles:
            – TitleFull: Frontiers in immunology
              Type: main
ResultId 1